Isola Therapeutics is an early stage startup emerging from the medical device incubator ConvergAscent that is developing a local drug delivery system to more effectively treat cancer while reducing systemic toxicity. The company is led by seasoned industry veterans in collaboration with experienced partners who have developed and commercialized numerous innovative medical devices.